Optometry News

SEATTLE — ChatGPT did not recognize several common symptoms of congenital glaucoma and did not recommend urgent evaluation by a pediatric eye care specialist, according to a poster presentation.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Daniela Ferrara, MD, PhD, FASRS, discusses AI-based machine learning models to predict the visual acuity treatment response of Vabysmo.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, John D. Sheppard, MD, MMSc, FACS, discusses a post hoc analysis investigating Miebo for the treatment of dry eye disease at different levels of severity.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Allen C. Ho, MD, FASRS, discusses 12-month data on MCO-010 optogenetic therapy for patients with retinitis pigmentosa.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Neda Gioia, OD, CNS, FOWNS, discusses two studies investigating a novel oral supplement from Bausch + Lomb for patients with dry eye disease.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Eric D. Donnenfeld, MD, discusses research that investigated Blink Triple Care artificial tears for the treatment of dry eye disease.

Adults with Down syndrome did not have significant differences in ciliary muscle morphology from typically developing adults, despite having lower visual acuity and greater accommodative lag, according to study results.

Qlaris Bio raised $24 million during series B financing for the clinical development of QLS-111, a new IOP-lowering drug candidate for patients with glaucoma, the company announced in a press release.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, William Reindel, OD, discusses the impact of pupil size on vision and comfort performance of a new multifocal daily disposable contact lens.

All day long, we doctors see patients who are much older than we are.